Guardian Pharmacy Services (GRDN) Asset Writedowns and Impairment (2023 - 2026)

Guardian Pharmacy Services (GRDN) has 4 years of Asset Writedowns and Impairment data on file, last reported at $1.1 million in Q1 2026.

• Quarterly Asset Writedowns and Impairment rose 18.53% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (down 19.14% YoY) and the FY2025 annual result came in at $4.6 million, down 28.08% from the prior year.
• Asset Writedowns and Impairment eased to $1.1 million in Q1 2026 per GRDN's latest filing, from $1.5 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $2.1 million in Q4 2024, with the low at $896000.0 in Q1 2025.
• Average Asset Writedowns and Impairment over 4 years is $1.3 million, with a median of $1.3 million recorded in 2023.
• Year-over-year, Asset Writedowns and Impairment jumped 56.27% in 2024 and tumbled 42.0% in 2025.
• Guardian Pharmacy Services' Asset Writedowns and Impairment stood at $1.4 million in 2023, then jumped by 56.27% to $2.1 million in 2024, then sank by 30.94% to $1.5 million in 2025, then fell by 27.8% to $1.1 million in 2026.
• Business Quant data shows GRDN's Asset Writedowns and Impairment at $1.1 million in Q1 2026, $1.5 million in Q4 2025, and $1.2 million in Q3 2025.